STABLE PHARMACEUTICAL COMPOSITION OF PEGINTERFERON ALPHA 2B

摘要

The present invention relates to the stable pharmaceutical compositions comprising PEG interferon alpha 2b. More particularly it relates to the stable pharmaceutical compositions comprising PEG interferon alpha 2b and cryoprotectant selected from the group consisting of 2 Hydroxy propyl beta cyclodextrin sucralose or polyvinylpyrrolidone 4000. It also relates to the methods of manufacturing the composition method of administration and kits containing the same.